Search

Denatonium

Adakitug

MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin-8) and may have potential application in oncology and inflammation. … HuMax-Inflam was also effective in reducing disease activity in palmoplantar pustulosis patients in a clinical study.

Plinabulin

Alcaftadine

Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.

Pazufloxacin

Pazufloxacin is under investigation in clinical trial NCT02592096 (Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol).

Alferminogene tadenovec

Alferminogene tadenovec, Cardium’s lead product candidate, is being developed for the potential treatment of myocardial ischemia that gives rise to angina symptoms associated with coronary heart disease

Bumetanide

Bumetanide is a sulfamyl diuretic.

NCX 1015

NCX 1015 is nitric oxide-releasing derivative of prednisolone developed for the treatment of inflammatory bowel disease (IBD) by NicOx SA.

Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine

As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. … Specifically, the COVID-19 infection relies on the binding of the Spike protein to an ACEII receptor, and with the described approach, the vaccine uses these engineered minigenes to express viral proteins

Dansylamide